Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, ...

leading to increased production of non-sickling and anti-sickling fetal hemoglobin (HbF) and thus mimicking the effects of naturally occurring variants seen in hereditary persistence of fetal ...

leading to increased production of non-sickling and anti-sickling fetal hemoglobin (HbF) and thus mimicking the effects of naturally occurring variants seen in hereditary persistence of fetal ...

Jan. 23, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines ... durable increases in fetal hemoglobin (HbF) and ...

including fetal anemia and hypoxia. This condition arises from genetic mutations that affect the production of hemoglobin, the protein in red blood cells responsible for carrying oxygen.

Beam Therapeutics shows promise in gene therapy for sickle cell disease, but it also has high risks and market expectations.

as they demonstrated the persistence of the payload features even after the NPs had been internalized. The integrity of the cells was considered to be an indicator of biocompatibility, and no ...

A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days -- in a single test and at a much lower cost.

Bad breath affects 25% of people worldwide. It can stem from various causes, including dry mouth, harmful bacteria on the tongue, and acid reflux. Effective ways to combat it include staying ...

Maternal vitamin D deficiency during pregnancy is linked to accelerated epigenetic gestational age in infants at birth, ...

Hemoglobinopathies: Disorders caused by abnormalities in the structure or production of hemoglobin. Thalassemia: A genetic blood disorder characterized by reduced production of one of the globin ...

Shares of Persistent Systems Ltd trades at expensive valuations, but following the IT firm's Q3 results, a few brokerages maintained their 'Buy' calls on the stock, with target prices suggesting ...